The Patent Finder

Mylan Technologies, Inc.

4 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Mar 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jul 5, 2027
    The maintenance fee for Stabilized Transdermal Drug Delivery System (US 9,226,902) comes due Jul 5, 2027. Unpaid by Jan 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 4 of 4

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,017,301Transdermal drug delivery systems comprising a coated release liner
In force
 · High confidence
In forceHigh confidence
US 7,955,677Two-Sided Non-Stick Release Film
In force
 · High confidence
In forceHigh confidence
US 7,888,422Long-Wearing Removable Pressure Sensitive Adhesive
In force
 · High confidence
In forceHigh confidence
US 9,226,902Stabilized Transdermal Drug Delivery System
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 4: 2 lapsed for an unpaid fee · 22 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

15 abandoned

Showing 1 to 10 of 15, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
15/945,420Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug DeliveryApr 4, 2018Abandoned
15/293,118Transdermal Systems Containing Multilayer Adhesive Matrices to Modify Drug DeliveryOct 13, 2016Abandoned
15/218,620Extended-Release Dosage FormJul 25, 2016Abandoned
14/700,316Transdermal Systems Having Control Delivery SystemApr 30, 2015Abandoned
14/899,957Storage Stable Transdermal Patch of RotigotineJun 20, 2014Abandoned
14/303,831Adhesive Mixture for Transdermal Delivery of Highly Plasticizing DrugsJun 13, 2014Abandoned
14/271,746Adhesive Mixture for Transdermal Delivery of Highly Plasticizing DrugsMay 7, 2014Abandoned
13/623,205Adhesive Mixture for Transdermal Delivery of Highly Plasticizing DrugsSep 20, 2012Abandoned
12/977,713Extended-Release Dosage FormDec 23, 2010Abandoned
12/571,509Amorphous Rotigotine Transdermal SystemOct 1, 2009Abandoned
10 of 15 applications shown.
Pro members see all 15 published applications.
Pro members: see all 15 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited